Updated November 14, 2012
Board of Governors
To identify and coordinate issues in personalized health care, prioritize those issues, and make recommendations for action to the CAP Board of Governors (BOG) and the appropriate established councils and committees within the College’s structure. The PHC mission and activities should be reviewed annually for relevance to the College’s vision and evaluated for a continued role or whether to sunset the Committee.
Number of face-to-face meetings: 3 per year
Length of each meeting: 1 to 1-1/2 days
Typical meeting days of the week: Friday and/or Saturday
Location of meetings: TBD
Number of conference calls: 2 per year
Hours of committee work required outside of
Member: 3 hours per month of outside work required
Chair: 20 hours per month may include some additional travel to Washington or conferences and other CAP meetings.
Additional travel or time commitments:
Committee member attendance at the CAP annual meeting is strongly encouraged.
The PHC will focus on coordination, monitoring and communication facilitation as it relates to personalized health care and its impact on key activities of the College including:
- Government advocacy
- Patient advocacy
- Proficiency testing
- Resources for reporting of pathology results of tests that have personalized health care implications such as risk stratification, therapy selection, etc.
- Education of pathologists regarding the concept and practice of personalized medicine and clinicals to understand pathology results as they pertain to personalized healthcare
Committee members must have a working knowledge of the science of personalized healthcare along with one or more specific areas of expertise:
- Medical Genetics
- Molecular Medicine
- Anatomic Pathology
- Clinical Pathology
- Public Policy and Economic Affairs
- Continuing Medical Education
Personalized health care will provide pathologists with an opportunity to highlight their unique contribution to clinical decision-making and patient care. As personalized health care becomes integrated into mainstream clinical practice, pathologists will become key consultants in the evaluation of individualized therapies based on genomic analyses likely including recommendation for specific prescription drugs and further diagnostic testing when necessary. Members of this committee will be guiding the professions evolution to this new focus on the practice of medicine.
Representation on committee beyond the CAP:
The PHC Committee consists of 13 members
- A chair who is a member of the CAP appointed by the President of CAP
- A vice chair appointed by the Chair
- 11 CAP members with expertise listed in one or more disciplines listed above